Skip to Content
Merck
CN

EHU157521

MISSION® esiRNA

targeting human ZCCHC11

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CCAGTTTACAGGCAAAAGCAGAAAAATCACCAAAGTCACCTAATTCAGTGAAAGCAGAAAAAGCATCCAGTTATCAGATGAAGTCAGAAAAAGTACCAAGTTCACCAGCAGAAGCAGAAAAGGGACCCAGTTTACTGTTGAAAGACATGAGACAGAAGACAGAATTACAACAGATTGGAAAAAAAATTCCAAGCTCCTTTACTTCTGTGGACAAAGTGAATATTGAAGCTGTAGGGGGAGAAAAATGTGCTCTGCAAAACTCACCACGATCTCAGAAGCAACAGACATGTACAGATAATACTGGTGATTCTGATGATAGTGCTTCAGGAATTGAAGACGTATCGGACGATTTAAGTAAAATGAAGAATGATGAATCTAATAAAGAAAATTCTTCAGAGATGGACTACTTAGAAAATGCCACTGTGATAGATGAATCTGCATTGACACCTGAGCAGAGGC

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... ZCCHC11(23318)

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



X Fu et al.
Oncogene, 33(34), 4296-4306 (2013-09-24)
Human cancers often exhibit attenuated microRNA (miRNA) biogenesis and global underexpression of miRNAs; thus, targeting the miRNA biogenesis pathway represents a novel strategy for cancer therapy. Here, we report that miR-26a enhances miRNA biogenesis, which acts as a common mechanism
Zbigniew Warkocki et al.
Cell, 174(6), 1537-1548 (2018-08-21)
LINE-1 retrotransposition is tightly restricted by layers of regulatory control, with epigenetic pathways being the best characterized. Looking at post-transcriptional regulation, we now show that LINE-1 mRNA 3' ends are pervasively uridylated in various human cellular models and in mouse



Global Trade Item Number

SKUGTIN
EHU157521-50UG04061828419012
EHU157521-20UG04061831367461